Confronto

Glepaglutide vs. Melanotan II

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

nessun dato

121062-08-6

Peso molecolare

nessun dato

1024.18 g/mol

Emivita

nessun dato

1 h

Sequenza

nessun dato

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

Meccanismo d'azione

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Melanotan II

Melanotan II binds non-selectively to all five melanocortin-receptor subtypes (MC1R-MC5R). Via MC1R in melanocytes, eumelanin synthesis is stimulated (pigmenting effect). Via MC4R and MC3R in the CNS, appetite, sexual function and blood pressure are modulated. The cyclic structure and D-amino acids increase stability compared to natural α-MSH.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Glepaglutide	Melanotan II
Australia	—	Vietato
Germania	Non approvato	Non approvato
Regno Unito	—	Vietato
Stati Uniti	Non approvato	Non approvato

Voci complete

Frequently asked questions

What is the difference between Glepaglutide and Melanotan II?: Glepaglutide is classified as "Ricerca (altro)", while Melanotan II is classified as "Ricerca (altro)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Melanotan II: Cyclic hepta-peptide and non-selective melanocortin-receptor agonist. Originally researched at the University of Arizona as a sun-protection concept — never approved as a medicine. Widespread on the black market; regulatory warnings for cardiovascular and oncological risks. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Glepaglutide or Melanotan II?: The highest available evidence level is "RCT sull'uomo" for Glepaglutide and "Studio sull'uomo" for Melanotan II. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Glepaglutide and Melanotan II in Germany and the United States?: Germania: Glepaglutide — Non approvato, Melanotan II — Non approvato. Stati Uniti: Glepaglutide — Non approvato, Melanotan II — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Glepaglutide

Melanotan II

Australia

—

Vietato

Germania

Non approvato

Regno Unito

—

Vietato

Stati Uniti

Non approvato

Frequently asked questions

What is the difference between Glepaglutide and Melanotan II?

Glepaglutide is classified as "Ricerca (altro)", while Melanotan II is classified as "Ricerca (altro)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Melanotan II: Cyclic hepta-peptide and non-selective melanocortin-receptor agonist. Originally researched at the University of Arizona as a sun-protection concept — never approved as a medicine. Widespread on the black market; regulatory warnings for cardiovascular and oncological risks. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Glepaglutide or Melanotan II?

The highest available evidence level is "RCT sull'uomo" for Glepaglutide and "Studio sull'uomo" for Melanotan II. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Glepaglutide and Melanotan II in Germany and the United States?

Germania: Glepaglutide — Non approvato, Melanotan II — Non approvato. Stati Uniti: Glepaglutide — Non approvato, Melanotan II — Non approvato. These are factual summaries with source and review date on the individual pages.